News Conference News HFSA 2025 Too Few HF Patients on Guideline-Directed Medical Therapy in VA System Yael L. Maxwell October 06, 2025
News Conference News HFSA 2025 Acoramidis Halves Cumulative CV Events Within 6 Months: ATTRibute-CM Yael L. Maxwell October 01, 2025
News Daily News Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data L.A. McKeown July 24, 2025
News Daily News AI Has Great Potential in CV Pharmacotherapy, but Much Work Lies Ahead: Review Todd Neale July 24, 2025
News Daily News Some Mitral TEER Patients Slipping Through the Cracks in the First Month Michael O'Riordan March 21, 2025
News Features GDMT Uptake Remains Dismal in HFrEF: What’s the Right Fix? Todd Neale November 13, 2024
News Daily News Yes, Clinical Inertia IS the Leading Cause of GDMT Underuse in HFrEF Todd Neale September 20, 2024
News Daily News Scoring System Puts Focus on Medical Therapy Optimization in HFrEF L.A. McKeown August 13, 2024
News Conference News ACC 2024 Early Empagliflozin Doesn’t Curb HF Hospitalizations, Deaths Post-MI: EMPACT-MI Shelley Wood April 06, 2024
News Opinion Off Script Evoque and Patisiran: A Tale of Two Regulatory Journeys Sanjay Kaul, MD March 29, 2024
News Daily News ICD Benefits Hold Up for Modern-day Primary Prevention, but Questions Remain Todd Neale March 25, 2024
News Daily News Most Takotsubo Patients Die From CV Causes, but Standard Meds No Help Todd Neale January 11, 2024
News Conference News AHA 2023 Seeing Sticker Price for HFrEF Meds Opens Door to Discussions Caitlin E. Cox November 14, 2023
News Daily News Global Numbers Paint Grim Picture of GDMT Uptake, Costs, and HF Outcomes Michael O'Riordan June 23, 2023
News Conference News ESC Heart Failure 2023 Boosting GDMT and Improving Outcomes? No Mean Task After AHF Shelley Wood June 01, 2023